Avantor: Subdued Outlook and Execution Risks Justify Hold Rating and Trimmed Target Price

In a report released today, Patrick B Donnelly from Citi maintained a Hold rating on Avantor, with a price target of $11.00.

Patrick B Donnelly has given his Hold rating due to a combination of factors related to Avantor’s subdued outlook and execution risks. Management’s initial 2026 guidance calls for a modest organic revenue decline, margins below prior market expectations, and EPS materially under consensus, all of which indicate only a gradual recovery rather than a strong near‑term inflection.

He also highlights that the first quarter of 2026 is likely to mark the low point for growth, profitability, and earnings, with limited benefit yet from the company’s Revival initiatives. While the VWR Distribution & Services segment should improve and eventually outgrow Bioscience & Medtech Products, ongoing pricing pressures, tougher comparisons in BMP, and the need to restore share and profitability constrain upside, leading him to maintain a Neutral stance and trim the target price.